Analysts Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) PT at $27.67

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) has been given a consensus recommendation of “Moderate Buy” by the six brokerages that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $27.67.

Several equities analysts have commented on KMTS shares. Wells Fargo & Company started coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They set an “overweight” rating and a $28.00 target price on the stock. The Goldman Sachs Group started coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They issued a “neutral” rating and a $24.00 price objective on the stock. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set a “buy” rating and a $28.00 target price for the company. Wolfe Research began coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an “outperform” rating and a $29.00 price target on the stock. Finally, Piper Sandler started coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They set an “overweight” rating and a $27.00 price objective for the company.

Kestra Medical Technologies Price Performance

KMTS opened at $23.27 on Monday. Kestra Medical Technologies has a fifty-two week low of $20.00 and a fifty-two week high of $26.06.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.